October 11, 2019




Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549


  Re: Titan Pharmaceuticals, Inc.

Registration Statement on Form S-1, as amended (File No. 333-233722)


Ladies and Gentlemen:


As the underwriter of the proposed offering of Titan Pharmaceuticals, Inc. (the “Company”), we hereby join the Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness for 9:15 a.m., Eastern Time, on October 15, 2019, or as soon thereafter as is practicable. 


The undersigned advise that they have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.


  Very truly yours,
  Maxim Group LLC
  By:  /s/ Clifford A. Teller
    Name: Clifford A. Teller
Title: Head of Investment Banking, Executive Managing Director